The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hydroxyzine Imine-Global Market Insights and Sales Trends 2025
Synopsis
Hydroxyzine imine are medications which are intended for an organic disease state when it manifests through anxiety. Hydroxyzine imine is a drug that attenuates activity in the central nervous system. This property aids hydroxyzine imine to treat anxiety and tension associated with psychoneurosis. Besides, it also acts as an antihistamine which reduces the actions of natural histamine in the body and hence can cure symptoms of itching, or hives on the skin.
The global Hydroxyzine Imine market size is expected to reach US$ 1138.9 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Hydroxyzine Imine in various end use industries. The expanding demands from the Urticaria, Histamine-Mediated Pruritus and Atopic and Contact Dermatoses,, are propelling Hydroxyzine Imine market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule segment is estimated at % CAGR for the next seven-year period.
Factors such as the increasing allergic reactions among the target population, an increase in investments and awareness campaigns, and a rise in the prevalence of anxiety disorders among the elderly population globally are the major factors that contribute to the market's growth. The prevalence of allergies or related diseases is increasing globally than the previous few decades. There are several factors that contribute to the rise in cases of allergic conditions. For instance, according to Allergy Facts and Figures updated in April 2022, nearly more than 50 million people in the United States experience various types of allergies every year, and allergies are the sixth major cause of chronic illness in the country. Thus, there is a high burden of allergies in the country, which requires better treatment options.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hydroxyzine Imine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hydroxyzine Imine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hydroxyzine Imine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hydroxyzine Imine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hydroxyzine Imine covered in this report include Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries, Shanghai Ruizheng Chemical Technology Co., Ltd, Lupin Pharmaceuticals, Inc., N&R Industries, OAK PHARMS INC., Changzhou ComWin Fine Chemicals Co., Ltd and Novartis International AG, etc.
The global Hydroxyzine Imine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer Inc.
GlaxoSmithKline plc
Teva Pharmaceutical Industries
Shanghai Ruizheng Chemical Technology Co., Ltd
Lupin Pharmaceuticals, Inc.
N&R Industries
OAK PHARMS INC.
Changzhou ComWin Fine Chemicals Co., Ltd
Novartis International AG
Impax Laboratories, Inc
Global Hydroxyzine Imine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hydroxyzine Imine market, Segment by Type:
Tablet
Capsule
Syrup
Injection
Global Hydroxyzine Imine market, by Application
Urticaria
Histamine-Mediated Pruritus and Atopic
Contact Dermatoses
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hydroxyzine Imine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Hydroxyzine imine are medications which are intended for an organic disease state when it manifests through anxiety. Hydroxyzine imine is a drug that attenuates activity in the central nervous system. This property aids hydroxyzine imine to treat anxiety and tension associated with psychoneurosis. Besides, it also acts as an antihistamine which reduces the actions of natural histamine in the body and hence can cure symptoms of itching, or hives on the skin.
The global Hydroxyzine Imine market size is expected to reach US$ 1138.9 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Hydroxyzine Imine in various end use industries. The expanding demands from the Urticaria, Histamine-Mediated Pruritus and Atopic and Contact Dermatoses,, are propelling Hydroxyzine Imine market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule segment is estimated at % CAGR for the next seven-year period.
Factors such as the increasing allergic reactions among the target population, an increase in investments and awareness campaigns, and a rise in the prevalence of anxiety disorders among the elderly population globally are the major factors that contribute to the market's growth. The prevalence of allergies or related diseases is increasing globally than the previous few decades. There are several factors that contribute to the rise in cases of allergic conditions. For instance, according to Allergy Facts and Figures updated in April 2022, nearly more than 50 million people in the United States experience various types of allergies every year, and allergies are the sixth major cause of chronic illness in the country. Thus, there is a high burden of allergies in the country, which requires better treatment options.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hydroxyzine Imine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hydroxyzine Imine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hydroxyzine Imine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hydroxyzine Imine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hydroxyzine Imine covered in this report include Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries, Shanghai Ruizheng Chemical Technology Co., Ltd, Lupin Pharmaceuticals, Inc., N&R Industries, OAK PHARMS INC., Changzhou ComWin Fine Chemicals Co., Ltd and Novartis International AG, etc.
The global Hydroxyzine Imine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer Inc.
GlaxoSmithKline plc
Teva Pharmaceutical Industries
Shanghai Ruizheng Chemical Technology Co., Ltd
Lupin Pharmaceuticals, Inc.
N&R Industries
OAK PHARMS INC.
Changzhou ComWin Fine Chemicals Co., Ltd
Novartis International AG
Impax Laboratories, Inc
Global Hydroxyzine Imine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hydroxyzine Imine market, Segment by Type:
Tablet
Capsule
Syrup
Injection
Global Hydroxyzine Imine market, by Application
Urticaria
Histamine-Mediated Pruritus and Atopic
Contact Dermatoses
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hydroxyzine Imine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Hydroxyzine Imine
1.1 Hydroxyzine Imine Market Overview
1.1.1 Hydroxyzine Imine Product Scope
1.1.2 Hydroxyzine Imine Market Status and Outlook
1.2 Global Hydroxyzine Imine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hydroxyzine Imine Market Size by Region (2018-2029)
1.4 Global Hydroxyzine Imine Historic Market Size by Region (2018-2023)
1.5 Global Hydroxyzine Imine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hydroxyzine Imine Market Size (2018-2029)
1.6.1 North America Hydroxyzine Imine Market Size (2018-2029)
1.6.2 Europe Hydroxyzine Imine Market Size (2018-2029)
1.6.3 Asia-Pacific Hydroxyzine Imine Market Size (2018-2029)
1.6.4 Latin America Hydroxyzine Imine Market Size (2018-2029)
1.6.5 Middle East & Africa Hydroxyzine Imine Market Size (2018-2029)
2 Hydroxyzine Imine Market by Type
2.1 Introduction
2.1.1 Tablet
2.1.2 Capsule
2.1.3 Syrup
2.1.4 Injection
2.2 Global Hydroxyzine Imine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hydroxyzine Imine Historic Market Size by Type (2018-2023)
2.2.2 Global Hydroxyzine Imine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hydroxyzine Imine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hydroxyzine Imine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hydroxyzine Imine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hydroxyzine Imine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hydroxyzine Imine Revenue Breakdown by Type (2018-2029)
3 Hydroxyzine Imine Market Overview by Application
3.1 Introduction
3.1.1 Urticaria
3.1.2 Histamine-Mediated Pruritus and Atopic
3.1.3 Contact Dermatoses
3.2 Global Hydroxyzine Imine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hydroxyzine Imine Historic Market Size by Application (2018-2023)
3.2.2 Global Hydroxyzine Imine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hydroxyzine Imine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hydroxyzine Imine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hydroxyzine Imine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hydroxyzine Imine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hydroxyzine Imine Revenue Breakdown by Application (2018-2029)
4 Hydroxyzine Imine Competition Analysis by Players
4.1 Global Hydroxyzine Imine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hydroxyzine Imine as of 2022)
4.3 Date of Key Players Enter into Hydroxyzine Imine Market
4.4 Global Top Players Hydroxyzine Imine Headquarters and Area Served
4.5 Key Players Hydroxyzine Imine Product Solution and Service
4.6 Competitive Status
4.6.1 Hydroxyzine Imine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer Inc.
5.1.1 Pfizer Inc. Profile
5.1.2 Pfizer Inc. Main Business
5.1.3 Pfizer Inc. Hydroxyzine Imine Products, Services and Solutions
5.1.4 Pfizer Inc. Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Inc. Recent Developments
5.2 GlaxoSmithKline plc
5.2.1 GlaxoSmithKline plc Profile
5.2.2 GlaxoSmithKline plc Main Business
5.2.3 GlaxoSmithKline plc Hydroxyzine Imine Products, Services and Solutions
5.2.4 GlaxoSmithKline plc Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline plc Recent Developments
5.3 Teva Pharmaceutical Industries
5.3.1 Teva Pharmaceutical Industries Profile
5.3.2 Teva Pharmaceutical Industries Main Business
5.3.3 Teva Pharmaceutical Industries Hydroxyzine Imine Products, Services and Solutions
5.3.4 Teva Pharmaceutical Industries Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.3.5 Shanghai Ruizheng Chemical Technology Co., Ltd Recent Developments
5.4 Shanghai Ruizheng Chemical Technology Co., Ltd
5.4.1 Shanghai Ruizheng Chemical Technology Co., Ltd Profile
5.4.2 Shanghai Ruizheng Chemical Technology Co., Ltd Main Business
5.4.3 Shanghai Ruizheng Chemical Technology Co., Ltd Hydroxyzine Imine Products, Services and Solutions
5.4.4 Shanghai Ruizheng Chemical Technology Co., Ltd Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.4.5 Shanghai Ruizheng Chemical Technology Co., Ltd Recent Developments
5.5 Lupin Pharmaceuticals, Inc.
5.5.1 Lupin Pharmaceuticals, Inc. Profile
5.5.2 Lupin Pharmaceuticals, Inc. Main Business
5.5.3 Lupin Pharmaceuticals, Inc. Hydroxyzine Imine Products, Services and Solutions
5.5.4 Lupin Pharmaceuticals, Inc. Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.5.5 Lupin Pharmaceuticals, Inc. Recent Developments
5.6 N&R Industries
5.6.1 N&R Industries Profile
5.6.2 N&R Industries Main Business
5.6.3 N&R Industries Hydroxyzine Imine Products, Services and Solutions
5.6.4 N&R Industries Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.6.5 N&R Industries Recent Developments
5.7 OAK PHARMS INC.
5.7.1 OAK PHARMS INC. Profile
5.7.2 OAK PHARMS INC. Main Business
5.7.3 OAK PHARMS INC. Hydroxyzine Imine Products, Services and Solutions
5.7.4 OAK PHARMS INC. Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.7.5 OAK PHARMS INC. Recent Developments
5.8 Changzhou ComWin Fine Chemicals Co., Ltd
5.8.1 Changzhou ComWin Fine Chemicals Co., Ltd Profile
5.8.2 Changzhou ComWin Fine Chemicals Co., Ltd Main Business
5.8.3 Changzhou ComWin Fine Chemicals Co., Ltd Hydroxyzine Imine Products, Services and Solutions
5.8.4 Changzhou ComWin Fine Chemicals Co., Ltd Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.8.5 Changzhou ComWin Fine Chemicals Co., Ltd Recent Developments
5.9 Novartis International AG
5.9.1 Novartis International AG Profile
5.9.2 Novartis International AG Main Business
5.9.3 Novartis International AG Hydroxyzine Imine Products, Services and Solutions
5.9.4 Novartis International AG Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.9.5 Novartis International AG Recent Developments
5.10 Impax Laboratories, Inc
5.10.1 Impax Laboratories, Inc Profile
5.10.2 Impax Laboratories, Inc Main Business
5.10.3 Impax Laboratories, Inc Hydroxyzine Imine Products, Services and Solutions
5.10.4 Impax Laboratories, Inc Hydroxyzine Imine Revenue (US$ Million) & (2018-2023)
5.10.5 Impax Laboratories, Inc Recent Developments
6 North America
6.1 North America Hydroxyzine Imine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hydroxyzine Imine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hydroxyzine Imine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hydroxyzine Imine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hydroxyzine Imine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hydroxyzine Imine Market Dynamics
11.1 Hydroxyzine Imine Industry Trends
11.2 Hydroxyzine Imine Market Drivers
11.3 Hydroxyzine Imine Market Challenges
11.4 Hydroxyzine Imine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
